Gerald Bingham

Gerald Bingham serves as a Contract Specialist within the National CMOP Office of the Department of Veterans Affairs, where he plays a pivotal role in securing the domestic production and distribution of mission-critical pharmaceuticals and medical supplies for veterans. His procurement activities center on ensuring supply chain resilience through the acquisition of sovereign manufacturing capabilities, with a focus on FDA-regulated products and medical consumables. Bingham manages complex solicitations under FAR Part 15, primarily utilizing negotiated procurements to meet stringent quality, security, and timeliness requirements essential to veteran healthcare readiness. He maintains established working relationships with a core group of specialized contractors, including ALL IN SOLUTIONS LLC, ANSIBLE GOVERNMENT SOLUTIONS LLC, and INNOVATION ASSOCIATES, INC., all of whom provide technical expertise in pharmaceutical formulation, sterile compounding, and diagnostic substance production. These partnerships reflect a preference for vendors with proven GMP compliance, FDA registration, and experience in federal supply chain operations. Bingham’s approach emphasizes long-term vendor reliability over transactional sourcing, fostering collaborative relationships grounded in regulatory adherence and operational continuity. His contracting patterns reflect a strong commitment to small business participation, with over 30% of awards structured as Total Small Business Set-Asides under FAR 19.5, and nearly 2.5% reserved for Service-Disabled Veteran-Owned Small Businesses. While the majority of acquisitions are open to all competitors, Bingham strategically deploys socioeconomic set-asides to strengthen the ecosystem of qualified small manufacturers capable of meeting CMOP’s high-bar standards. Bingham’s primary procurement focus lies in NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 325413 (In-Vitro Diagnostic Substance Manufacturing), reflecting deep expertise in sterile injectables, radiopharmaceuticals, and diagnostic reagents. He also oversees industrial laundering services under NAICS 812332 to support sterile field supply chains. His domain knowledge encompasses cGMP, validation protocols, and controlled substance logistics, making him a key steward of the nation’s domestic medical manufacturing infrastructure.